XBiotech Inc.
NASDAQ:XBITBiotechnology
-$0.02 today
- Market cap
- $51.22M
- Beta
- 0.84
- P/E (TTM)
- -1.8
- EPS (TTM)
- -$1.32
Volume 0.05M
Average 0.03M
Returns on capital
XBiotech Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-32.4%
avg -21.1%
ROIC
-39.2%
avg -30.9%
ROA
-30.3%
avg -19.5%
Analysis
ROA is currently the strongest return metric at -30.3% versus its period average of -19.5%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
John Simard | Founder & Chairman | USD 27.13M | 64 | 4.26M | 13.98% |
Sushma Shivaswamy | Co-CEO & Chief Scientific Officer | USD 570.99K | 48 | 100.00K | 0.33% |
Angela Hu | Director of Finance | USD 245.42K | 42 | 30.00K | 0.10% |
Qian Wu | Senior Vice President of Clinical Operations & Analytical Quality | — | — | — | — |
Jan-Paul Simard | Co-Chief Executive Officer | — | 24 | 2.00M | 6.56% |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Nov 3, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
2
$854,660.32
Sells
0
$0.00
Net Transaction Value
+$854,660.32
Net buying
Most Active
SIMARD JOHN
2 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Nov 3, 26Nov 3, 2026 | SIMARD JOHN Direct | Buy | $143.4K$143,409.00 |
| Oct 26, 26Oct 26, 2026 | SIMARD JOHN Direct | Buy | $711.3K$711,251.32 |
Summary
Insiders reported 2 buys worth $854,660.32 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $854,660.32. SIMARD JOHN was the most active insider with 2 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Competitors
Who does XBiotech Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Questions
Management questions
Common questions about XBIT's management, answered from reported figures.
Who manages XBIT?
XBiotech Inc. (XBIT) lists 5 active executives. The top listed executive is Qian Wu, Senior Vice President of Clinical Operations & Analytical Quality.
Are XBIT insiders buying or selling?
Recent insider activity shows net selling of $406.71M.
Continue the stock analysis
Jump to another research area for this company.